Home/Filings/4/0001209191-18-015680
4//SEC Filing

Smith Patton Paul 4

Accession 0001209191-18-015680

CIK 0001108109other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 4:35 PM ET

Size

15.3 KB

Accession

0001209191-18-015680

Insider Transaction Report

Form 4
Period: 2018-03-01
Smith Patton Paul
Division President
Transactions
  • Award

    Common Stock

    2018-03-01+30,00098,369 total
  • Tax Payment

    Common Stock

    2018-03-01$4.58/sh4,952$22,68093,417 total
  • Award

    Performance Based Restricted

    2018-03-01+30,00030,000 total
    Exercise: $0.00From: 2021-03-01Exp: 2028-02-28Common Stock (30,000 underlying)
Holdings
  • Stock Options (Right to Buy)

    Exercise: $30.32From: 2011-02-24Exp: 2020-02-23Common Stock (1,000 underlying)
    1,000
  • Stock Options (Right to Buy)

    Exercise: $34.38From: 2012-02-23Exp: 2021-02-22Common Stock (1,000 underlying)
    1,000
  • Performance Based Restricted

    Exercise: $0.00From: 2020-03-01Exp: 2027-02-28Common Stock (20,000 underlying)
    20,000
  • Stock Options (Right to Buy)

    Exercise: $17.49From: 2013-02-16Exp: 2022-02-15Common Stock (1,000 underlying)
    1,000
Footnotes (3)
  • [F1]The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.
  • [F2]The vesting of 50% of these performance-based restricted shares is subject to the attainment of a pre-determined level of Cumulative Same-Store Adjusted EBITDA Growth between January 1, 2018 and December 31, 2020 (the "2018-2020 Performance Period"). The vesting of the remaining 50% of these performance-based restricted shares is subject to the attainment of a pre-determined level of Cumulative Same-Store Adjusted EBITDA Margin Improvement for the 2018-2020 Performance Period. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the target number of performance-based restricted shares subject to the attainment of the Cumulative Same-Store Adjusted EBITDA Growth and Cumulative Same-Store Adjusted EBITDA Margin Improvement criteria, as applicable, will ultimately vest on the third anniversary of the date of grant, with the vesting percentage to be determined based upon achievement with respect to the
  • [F3]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between January 1, 2017 and December 31, 2019 (the "2017-2019 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the target number of performance-based restricted shares subject to the attainment of the applicable performance objectives will ultimately vest on the third anniversary of the date of grant, with the vesting percentage to be determined based upon achievement with respect to the applicable criteria during the 2017-2019 Performance Period.

Issuer

COMMUNITY HEALTH SYSTEMS INC

CIK 0001108109

Entity typeother

Related Parties

1
  • filerCIK 0001665775

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:35 PM ET
Size
15.3 KB